Tag: Rare lung cancer mutations

Home / Rare lung cancer mutations

Categories

Tepotinib is approved by the USFDA for metastatic non-small cell lung cancer

The Food and Drug Administration officially approved tepotinib (Tepmetko, EMD Serono, Inc.) on February 15, 2024, for adult patients with metastatic non-small cell lung cancer (NSCLC) that had mesenc...
rare-lung-cancer-mutations

Scan the code